News Sarepta files controversial Duchenne drug in EU US biotech seeks conditional approval for eteplirsen in EU.
Views & Analysis Digital health round-up: can Xcertia clear the health app co... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Events Partner Content Making Pharmaceuticals 25 & 26 April 2017 Exhibition & Conference for Pharma Professionals
Views & Analysis A new age: the real-world development pathway Pharma must be prepared to work collaboratively to establish the best benefit-risk profiles and outcomes.
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
